Zevra therapeutics to present at 35th annual roth conference

Celebration, fla., march 06, 2023 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (“zevra” or the “company” and formerly kempharm, inc.), a rare disease therapeutics company, today announced that richard w. pascoe, the company's chief executive officer, will participate in a fireside chat at the 35th annual roth conference on monday, march 13, 2023, at 2:00 p.m. pt. in addition, zevra management will be available for in-person or virtual one-on-one investor meetings during the conference from march 12-14.
ZVRA Ratings Summary
ZVRA Quant Ranking